Skip to content

A Prospective Observational Study of the Association Between Postprocedural Minimum Lumen Diameter and Access Patency After Balloon Angioplasty forArteriovenous Fistula

A Prospective Cohort Study on Success Criteria for Arteriovenous Fistula Percutaneous Endovascular Angioplasty Based on Postoperative Minimum Lumen Diameter

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125332
Enrollment
Unknown
Registered
2026-05-25
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arteriovenous fistula stenosis

Interventions

control group (minimum luminal diameter=5mm):None

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 and <=85 years; 2. The patient's AVF is mature and has successfully completed hemodialysis at least once; 3. The target lesion is located in the AVF outflow vein and the venous-side anastomosis; 4. Ultrasound or angiography assesses a hemodynamically significant AVF outflow vein stenosis of , and any of the following clinical symptoms or indicators are present: markedly elevated venous pressure during dialysis, abnormal physical examination, decreased pump-controlled blood flow, reduced dialysis adequacy, arterial blood flow or a decrease of compared with the previous follow-up; 5. The target lesion is a primary or restenotic lesion, consisting of one or more tandem lesions; 6 The patient voluntarily signs an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have undergone major surgical treatment within 30 days prior to enrollment in the study; 2. Calcified lesions that are expected not to be dilatable with a balloon; 3. Patients with mural thrombus at the site of luminal stenosis; 4. Target lesions located in a feeding artery or an arterial anastomosis; 5. Patients with an expected life expectancy of less than one year; 6. Patients who have received a kidney transplant, are scheduled to receive a kidney transplant, or are switching to peritoneal dialysis; 7. Vascular access infection or active systemic infection; 8. Presence of other medical conditions that, in the investigator's judgment, make the patient unsuitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
primary patency rate of the target lesion at 6 months postoperatively;

Secondary

MeasureTime frame
primary patency rate of the target lesion at 12 months postoperatively;

Countries

China

Contacts

Public ContactLihong Zhang

Beijing Haidian Hospital

zhanglihongzhu@163.com+86 10 82693132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026